𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of recurrent paget's disease of the vulva with topical bleomycin

✍ Scribed by Watson G. Watring; James A. Roberts; Leo D. Lagasse; Michael L. Berman; Samuel C. Ballon; J. George Moore; Roger E. Schlesinger


Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
169 KB
Volume
41
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Topical bleomycin for the treatment of d
✍ Joel B. Epstein; Meir Gorsky; Frances L. W. Wong; Amelia Millner πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 1 views

## BACKGROUND. Because malignant transformation of dysplastic oral leukoplakia has been reported in up to 43% of cases, these lesions must be managed. ## METHODS. This study evaluated the use of topical 1% bleomycin in dimethylsulfoxide for the treatment of dysplastic oral lesions. Bleomycin wa

The conservative management of Paget's d
✍ Lori J. Pierce; Bruce G. Haffty; Lawrence J. Solin; Beryl McCormick; Frank A. Vi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

## RESULTS. The median follow-up for surviving patients was 62 months. Three pa- ## Michigan. tients (10%) developed a recurrence in the breast as the only site of first failure,

Treatment of MOPP-refractory Hodgkin-s d
✍ Lawrence H. Einhorn; Stephen D. Williams; Eugene E. Stevens; William H. Bond; Li πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Eighteen patients with advanced Hodgkin's disease, refractory to combination chemotherapy with nitrogen mustard, vincristine, prednisone, and procarbazine (MOPP), were treated with vinblastine, doxorubicin (Adriamycin), bleomycin, CCNU, and dacarbazine (DTIC) (VABCD). Fifteen patients had Stage IV d

Treatment of advanced Hodgkin's disease
✍ John G. Krikorian; Carol S. Portlock; Dr. Saul A. Rosenberg πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 359 KB πŸ‘ 2 views

twenty-seven patients with advanced Hodgkin's disease who failed MOPP (nitrogen mustard, vincristine, procarbazine and prednisone) were treated with adriamycin, bleomycin, vinblastine, and imidazole carboxamide, (ABVD). Complete response (CR) was achieved in 22% of patients and partial response was